The role of infarct size in early and late mortality

Area of Science:

• Cardiology
• Biochemistry

Background:

• Acute myocardial infarction (AMI) poses significant morbidity and mortality risks.
• Understanding factors influencing patient outcomes post-AMI is crucial for effective clinical management.

Purpose of the Study:

• To assess the relationship between infarct size and short-term/long-term outcomes in patients experiencing their first AMI.
• To determine if infarct size predicts in-hospital complications, mortality, and long-term adverse events.

Main Methods:

• Blood samples were analyzed for creatine phosphokinase-MB (CPK-MB) levels to estimate infarct size in 144 consecutive AMI patients.
• Infarct size was correlated with the development of in-hospital complications (arrhythmias, heart failure, mechanical complications), mortality, and long-term outcomes.
• Resting thallium-201 perfusion defects were assessed post-discharge to evaluate residual ischemia.

Main Results:

• Enzymatically estimated infarct size was significantly larger in patients who experienced in-hospital arrhythmias, congestive heart failure, mechanical complications, or died.
• A correlation was observed between infarct size and the extent of thallium-201 perfusion defects after hospital discharge.
• Infarct size did not predict the occurrence of long-term complications following AMI.

Conclusions:

• Infarct size is a critical determinant of short-term prognosis following acute myocardial infarction.
• Long-term patient follow-up and prognosis are influenced by a complex interplay of left ventricular dysfunction, residual ischemia, and arrhythmogenic potential, rather than infarct size alone.